Results
|
|
81.
|
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. [electronic resource] by
- Campos, Susanna M
- Matulonis, Ursula A
- Penson, Richard T
- Lee, Hang
- Berkowitz, Ross S
- Duska, Linda R
- Fuller, Arlan F
- Wilson, Kara S
- Puchalski, Thomas A
- Supko, Jeffrey G
- Seiden, Michael V
Producer: 20031020
In:
Gynecologic oncology vol. 90
Availability: No items available.
|
|
|
82.
|
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1. [electronic resource] by
- Howitt, Brooke E
- Shukla, Sachet A
- Sholl, Lynette M
- Ritterhouse, Lauren L
- Watkins, Jaclyn C
- Rodig, Scott
- Stover, Elizabeth
- Strickland, Kyle C
- D'Andrea, Alan D
- Wu, Catherine J
- Matulonis, Ursula A
- Konstantinopoulos, Panagiotis A
Producer: 20160418
In:
JAMA oncology vol. 1
Availability: No items available.
|
|
|
83.
|
Combined MEK and BCL-2/X [electronic resource] by
- Iavarone, Claudia
- Zervantonakis, Ioannis K
- Selfors, Laura M
- Palakurthi, Sangeetha
- Liu, Joyce F
- Drapkin, Ronny
- Matulonis, Ursula A
- Hallberg, Dorothy
- Velculescu, Victor E
- Leverson, Joel D
- Sampath, Deepak
- Mills, Gordon B
- Brugge, Joan S
Producer: 20200312
In:
Molecular cancer therapeutics vol. 18
Availability: No items available.
|
|
|
84.
|
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. [electronic resource] by
- Strickland, Kyle C
- Howitt, Brooke E
- Shukla, Sachet A
- Rodig, Scott
- Ritterhouse, Lauren L
- Liu, Joyce F
- Garber, Judy E
- Chowdhury, Dipanjan
- Wu, Catherine J
- D'Andrea, Alan D
- Matulonis, Ursula A
- Konstantinopoulos, Panagiotis A
Producer: 20171218
In:
Oncotarget vol. 7
Availability: No items available.
|
|
|
85.
|
Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial. [electronic resource] by
- Lu, Weidong
- Matulonis, Ursula A
- Doherty-Gilman, Anne
- Lee, Hang
- Dean-Clower, Elizabeth
- Rosulek, Andrew
- Gibson, Carolyn
- Goodman, Annekathryn
- Davis, Roger B
- Buring, Julie E
- Wayne, Peter M
- Rosenthal, David S
- Penson, Richard T
Producer: 20091020
In:
Journal of alternative and complementary medicine (New York, N.Y.) vol. 15
Availability: No items available.
|
|
|
86.
|
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. [electronic resource] by
- Bentink, Stefan
- Haibe-Kains, Benjamin
- Risch, Thomas
- Fan, Jian-Bing
- Hirsch, Michelle S
- Holton, Kristina
- Rubio, Renee
- April, Craig
- Chen, Jing
- Wickham-Garcia, Eliza
- Liu, Joyce
- Culhane, Aedin
- Drapkin, Ronny
- Quackenbush, John
- Matulonis, Ursula A
Producer: 20120731
In:
PloS one vol. 7
Availability: No items available.
|
|
|
87.
|
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. [electronic resource] by
- Matulonis, Ursula A
- Harter, Philipp
- Gourley, Charlie
- Friedlander, Michael
- Vergote, Ignace
- Rustin, Gordon
- Scott, Clare
- Meier, Werner
- Shapira-Frommer, Ronnie
- Safra, Tamar
- Matei, Daniela
- Fielding, Anitra
- Spencer, Stuart
- Parry, David
- Grinsted, Lynda
- Ledermann, Jonathan A
Producer: 20170315
In:
Cancer vol. 122
Availability: No items available.
|
|
|
88.
|
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial. [electronic resource] by
- Liu, Joyce F
- Herold, Christina
- Gray, Kathryn P
- Penson, Richard T
- Horowitz, Neil
- Konstantinopoulos, Panagiotis A
- Castro, Cesar M
- Hill, Sarah J
- Curtis, Jennifer
- Luo, Weixiu
- Matulonis, Ursula A
- Cannistra, Stephen A
- Dizon, Don S
Producer: 20210616
In:
JAMA oncology vol. 5
Availability: No items available.
|
|
|
89.
|
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors. [electronic resource] by
- Penson, Richard T
- Dizon, Don S
- Cannistra, Stephen A
- Roche, Maria R
- Krasner, Carolyn N
- Berlin, Suzanne T
- Horowitz, Neil S
- Disilvestro, Paul A
- Matulonis, Ursula A
- Lee, Hang
- King, Modjulie A
- Campos, Susana M
Producer: 20100107
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
90.
|
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer. [electronic resource] by
- Gockley, Allison
- Melamed, Alexander
- Cronin, Angel
- Bookman, Michael A
- Burger, Robert A
- Cristae, Mihaela C
- Griggs, Jennifer J
- Mantia-Smaldone, Gina
- Matulonis, Ursula A
- Meyer, Larissa A
- Niland, Joyce
- O'Malley, David M
- Wright, Alexi A
Producer: 20200318
In:
American journal of obstetrics and gynecology vol. 221
Availability: No items available.
|
|
|
91.
|
Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors. [electronic resource] by
- Moore, Kathleen N
- Borghaei, Hossein
- O'Malley, David M
- Jeong, Woondong
- Seward, Shelly M
- Bauer, Todd M
- Perez, Raymond P
- Matulonis, Ursula A
- Running, Kelli L
- Zhang, Xiaoyan
- Ponte, Jose F
- Ruiz-Soto, Rodrigo
- Birrer, Michael J
Producer: 20170911
In:
Cancer vol. 123
Availability: No items available.
|
|
|
92.
|
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer. [electronic resource] by
- O'Malley, David M
- Matulonis, Ursula A
- Birrer, Michael J
- Castro, Cesar M
- Gilbert, Lucy
- Vergote, Ignace
- Martin, Lainie P
- Mantia-Smaldone, Gina M
- Martin, Antonio González
- Bratos, Raquel
- Penson, Richard T
- Malek, Karim
- Moore, Kathleen N
Producer: 20201030
In:
Gynecologic oncology vol. 157
Availability: No items available.
|
|
|
93.
|
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. [electronic resource] by
- Viswanathan, Akila N
- Moughan, Jennifer
- Miller, Brigitte E
- Xiao, Ying
- Jhingran, Anuja
- Portelance, Lorraine
- Bosch, Walter R
- Matulonis, Ursula A
- Horowitz, Neil S
- Mannel, Robert S
- Souhami, Luis
- Erickson, Beth A
- Winter, Kathryn A
- Small, William
- Gaffney, David K
Producer: 20160831
In:
Cancer vol. 121
Availability: No items available.
|
|
|
94.
|
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. [electronic resource] by
- Penson, Richard T
- Moore, Kathleen M
- Fleming, Gini F
- Braly, Patricia
- Schimp, Veronica
- Nguyen, Hoa
- Matulonis, Ursula A
- Banerjee, Susana
- Haluska, Paul
- Gore, Martin
- Bodurka, Diane C
- Hozak, Rebecca R
- Joshi, Adarsh
- Xu, Yihuan
- Schwartz, Jonathan D
- McGuire, William P
Producer: 20141103
In:
Gynecologic oncology vol. 134
Availability: No items available.
|
|
|
95.
|
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. [electronic resource] by
- Meyer, Larissa A
- Cronin, Angel M
- Sun, Charlotte C
- Bixel, Kristin
- Bookman, Michael A
- Cristea, Mihaela C
- Griggs, Jennifer J
- Levenback, Charles F
- Burger, Robert A
- Mantia-Smaldone, Gina
- Matulonis, Ursula A
- Niland, Joyce C
- O'Malley, David M
- Wright, Alexi A
Producer: 20171219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34
Availability: No items available.
|
|
|
96.
|
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer. [electronic resource] by
- Lee, Jung-Min
- Trepel, Jane B
- Choyke, Peter
- Cao, Liang
- Sissung, Tristan
- Houston, Nicole
- Yu, Minshu
- Figg, William D
- Turkbey, Ismail Baris
- Steinberg, Seth M
- Lee, Min-Jung
- Ivy, S Percy
- Liu, Joyce F
- Matulonis, Ursula A
- Kohn, Elise C
Producer: 20150617
In:
Frontiers in oncology vol. 5
Availability: No items available.
|
|
|
97.
|
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study). [electronic resource] by
- Makker, Vicky
- Recio, Fernando O
- Ma, Ling
- Matulonis, Ursula A
- Lauchle, Jennifer O
- Parmar, Hema
- Gilbert, Houston N
- Ware, Joseph A
- Zhu, Rui
- Lu, Shan
- Huw, Ling-Yuh
- Wang, Yulei
- Koeppen, Hartmut
- Spoerke, Jill M
- Lackner, Mark R
- Aghajanian, Carol A
Publication details: Cancer Nov 2016
In:
Cancer vol. 122
Availability: No items available.
|
|
|
98.
|
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. [electronic resource] by
- Castells, Mariana C
- Tennant, Nichole M
- Sloane, David E
- Hsu, F Ida
- Barrett, Nora A
- Hong, David I
- Laidlaw, Tanya M
- Legere, Henry J
- Nallamshetty, Samridhi N
- Palis, Ross I
- Rao, Jayanti J
- Berlin, Suzanne T
- Campos, Susana M
- Matulonis, Ursula A
Producer: 20081001
In:
The Journal of allergy and clinical immunology vol. 122
Availability: No items available.
|
|
|
99.
|
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. [electronic resource] by
- Ritterhouse, Lauren L
- Nowak, Jonathan A
- Strickland, Kyle C
- Garcia, Elizabeth P
- Jia, Yonghui
- Lindeman, Neal I
- Macconaill, Laura E
- Konstantinopoulos, Panagiotis A
- Matulonis, Ursula A
- Liu, Joyce
- Berkowitz, Ross S
- Nucci, Marisa R
- Crum, Christopher P
- Sholl, Lynette M
- Howitt, Brooke E
Producer: 20180123
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 29
Availability: No items available.
|
|
|
100.
|
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. [electronic resource] by
- Matulonis, Ursula A
- Berlin, Suzanne
- Ivy, Percy
- Tyburski, Karin
- Krasner, Carolyn
- Zarwan, Corrine
- Berkenblit, Anna
- Campos, Susana
- Horowitz, Neil
- Cannistra, Stephen A
- Lee, Hang
- Lee, Julie
- Roche, Maria
- Hill, Margaret
- Whalen, Christin
- Sullivan, Laura
- Tran, Chau
- Humphreys, Benjamin D
- Penson, Richard T
Producer: 20100105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|